The consortium consists of 31 research groups across Switzerland and Israel, headed from its home institution, the University of Basel.
AntiResist research groups in the following institutions are also in Basel:
The network also includes researchers from the following institutions:
Private Sector Collaborations
We have current collaborations with Roche, Spexis, BioVersys and Basilea with plans to build more of these relationships and establish a strong foundation for drug development using our research.